Evidence map›Paper›PMID 16293781›Full record

Trial reportCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2005

Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial.

Julie Ménard, Hélène Payette, Jean-Patrice Baillargeon, Pierre Maheux, Serge Lepage, Daniel Tessier, Jean-Luc Ardilouze

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Effectiveness of disease-management programs for improving diabetes care: a meta-analysis.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2011
    Pooled it
  7. Pooled it
  8. Diabetes: glycaemic control in type 2.BMJ clinical evidence · 2008
    Pooled it
  9. Trial
  10. Review
  11. Review
  12. Review
  13. Diabetes self-management education: miles to go.Nursing research and practice · 2013
    Article
  14. Article
  15. Drug management for hypertension in type 2 diabetes in family practice.Canadian family physician Medecin de famille canadien · 2009
    Article
  16. Article
  17. Article
  18. Multitherapy for diabetes.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2006
    Article
  19. Multitherapy for diabetes.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2006
    Article
  20. Can diabetes management programs create sustained improvements in disease outcomes?CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2005
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Julie MénardDiabetes and Metabolism Research Group, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada. julie.menard@chus.qc.ca
Hélène Payette
Jean-Patrice Baillargeon
Pierre Maheux
Serge Lepage
Daniel Tessier
Jean-Luc Ardilouze

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNational guidelines for managing diabetes set standards for care. We sought to determine whether a 1-year intensive multitherapy program resulted in greater goal attainment than usual care among patients with poorly controlled type 2 diabetes mellitus.

methodsWe identified patients with poorly controlled type 2 diabetes receiving outpatient care in the community or at our hospital. Patients 30-70 years of age with a hemoglobin A1c concentration of 8% or greater were randomly assigned to receive intensive multitherapy (n = 36) or usual care (n = 36).

resultsThe average hemoglobin A1c concentration at entry was 9.1% (standard deviation [SD] 1%) in the intensive therapy group and 9.3% (SD 1%) in the usual therapy group. By 12 months, a higher proportion of patients in the intensive therapy group than in the control group had achieved Canadian Diabetes Association (CDA) goals for hemoglobin A(1c) concentrations (goal < or = 7.0%: 35% v. 8%), diastolic blood pressure (goal < 80 mm Hg: 64% v. 37%), low-density lipoprotein cholesterol (LDL-C) levels (goal < 2.5 mmol/L: 53% v. 20%) and triglyceride levels (goal < 1.5 mmol/L: 44% v. 14%). There were no significant differences between the 2 groups in attaining the targets for fasting plasma glucose levels, systolic blood pressure or total cholesterol:high-density lipoprotein cholesterol ratio. None of the patients reached all CDA treatment goals. By 18 months, differences in goal attainment were no longer evident between the 2 groups, except for LDL-C levels. Quality of life, as measured by a specific questionnaire, increased in both groups, with a greater increase in the intensive therapy group (13% [SD 10%] v. 6% [SD 13%], p < 0.003).

interpretationIntensive multitherapy for patients with poorly controlled type 2 diabetes is successful in helping patients meet most of the goals set by a national diabetes association. However, 6 months after intensive therapy stopped and patients returned to usual care, the benefits had vanished.

Indexed as

ExerciseAdultAgedBlood GlucoseBlood PressureCholesterol, LDLDiabetes Mellitus, Type 2DyslipidemiasEnergy IntakeFemaleFollow-Up StudiesGlyburideGlycated HemoglobinHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypertensionBlood GlucoseCholesterol, LDLGlyburideGlycated HemoglobinHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsInsulinTriglycerides

Identifiers

PMID16293781
PMCPMC1316161

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.